About: Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) ലേഖനം (ml) wetenschappelijk artikel (nl) article scientifique publié en 2009 (fr) наукова стаття, опублікована у квітні 2009 (uk) im April 2009 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56837794-30CA6F28-6BA0-433A-BB1C-9DBFC52EB2E7
publication date	2009-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56837794-E482F27E-0B3B-4507-A21D-1DFF0E370E86
language of work or name	English
author name string	wds:Q56837794-591FFF22-DBC3-4F36-BE02-0A8B03930C5A wds:Q56837794-72ACE452-4BDC-4158-BC2D-56E991B77EBA wds:Q56837794-9FFFD3F0-BC1E-42F0-99A8-D2E6FC33F136
author name string	Sylvie Rozenberg Sami Kolta Claudine Duvivier
rdfs:label	Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (en) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (nl)
skos:prefLabel	Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (en) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (nl)
name	Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (en) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (nl)
author	wds:Q56837794-1F87863A-DD5F-43F6-8F0A-0F8A0D7DB62A wds:Q56837794-4A6E3E21-F043-4565-BA9D-3C8B66A143A9 wds:Q56837794-74EFC7D8-EDEA-42C8-B08B-48F99BB8B9CD wds:Q56837794-9732033B-07B0-47C0-825A-8988F8526C45 wds:Q56837794-9C2A1B7D-64FD-4A68-B8DD-65988FB806A6
author	Dominique Costagliola Robert L. Murphy Christine Katlama Lambert Assoumou Jade Ghosn
title	wds:Q56837794-29F8A13C-BC7C-4B16-92D6-68A58CF3A416
title	Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients (en)
page(s)	wds:Q56837794-FF994E24-1308-40C5-98E4-A1CE36649504
page(s)	817-824
instance of	wds:Q56837794-E4DF1D9A-7FFC-4300-811B-A1C818CB5ED5
instance of	scholarly article
main subject	wds:Q56837794-122510A6-6A53-4512-A872-C290402EE4D8 wds:Q56837794-46349285-E7B4-4B93-9F10-BF7758919CAA
main subject	HIV Patients
PubMed ID	wds:Q56837794-47488455-A25A-4418-B607-6C6F238F1704
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19363330
PubMed ID	19363330
published in	wds:Q56837794-6E9DCD49-7A69-45D2-949A-79E429B9076C
published in	AIDS
issue	wds:Q56837794-5947A07A-028B-46B5-BEDE-7E412F83A7E4
volume	wds:Q56837794-FE733580-9F3D-464D-9C70-12CAB4C02C94
issue	7
volume	27
DOI	wds:Q56837794-4711FD6F-0935-4C4D-AE65-BB7BDE3C2027
DOI	http://dx.doi.org/10.1097/QAD.0B013E328328F789
DOI	10.1097/QAD.0B013E328328F789
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56837794
is cites work of	Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine Short-term bone loss in HIV-infected premenopausal women Current and Novel Inhibitors of HIV Protease HIV and its effects on bone: a primer for rheumatologists Noncanonical Wnt signaling promotes osteoclast differentiation and is facilitated by the human immunodeficiency virus protease inhibitor ritonavir HIV: inflammation and bone Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial Increased risk of fragility fractures among HIV infected compared to uninfected male veterans Bone disease in HIV infection: a practical review and recommendations for HIV care providers HIV and bone metabolism HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study Bone alterations associated with HIV. Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens HIV and bone loss Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B. Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy. Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIV Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy. Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal Metabolic complications and treatment of perinatally HIV-infected children and adolescents Retroviral proteases and their roles in virion maturation HIV medications: an update and review of metabolic complications Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients. Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal women

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software